Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Phillip Michaels"'
Publikováno v:
Leukemia Research Reports, Vol 17, Iss , Pp 100320- (2022)
Acute promyelocytic leukemia (APL) is a unique leukemia that is characterized by the PML::RARA fusion. This fusion is often detected by conventional karyotype and fluorescence in situ hybridization (FISH); however, rare cases are cryptic and require
Externí odkaz:
https://doaj.org/article/f9b252612b9c42f7ae3306720b1cc884
Autor:
Michael J. Andersen, Poorva Bindal, Phillip Michaels, Pavania Elavalakanar, Ajoy L. Dias, Jon E. Arnason, Rushad Patell
Publikováno v:
Blood. 140:10985-10986
Autor:
Joseph D. Khoury, Eric Solary, Oussama Abla, Yassmine Akkari, Rita Alaggio, Jane F. Apperley, Rafael Bejar, Emilio Berti, Lambert Busque, John K. C. Chan, Weina Chen, Xueyan Chen, Wee-Joo Chng, John K. Choi, Isabel Colmenero, Sarah E. Coupland, Nicholas C. P. Cross, Daphne De Jong, M. Tarek Elghetany, Emiko Takahashi, Jean-Francois Emile, Judith Ferry, Linda Fogelstrand, Michaela Fontenay, Ulrich Germing, Sumeet Gujral, Torsten Haferlach, Claire Harrison, Jennelle C. Hodge, Shimin Hu, Joop H. Jansen, Rashmi Kanagal-Shamanna, Hagop M. Kantarjian, Christian P. Kratz, Xiao-Qiu Li, Megan S. Lim, Keith Loeb, Sanam Loghavi, Andrea Marcogliese, Soheil Meshinchi, Phillip Michaels, Kikkeri N. Naresh, Yasodha Natkunam, Reza Nejati, German Ott, Eric Padron, Keyur P. Patel, Nikhil Patkar, Jennifer Picarsic, Uwe Platzbecker, Irene Roberts, Anna Schuh, William Sewell, Reiner Siebert, Prashant Tembhare, Jeffrey Tyner, Srdan Verstovsek, Wei Wang, Brent Wood, Wenbin Xiao, Cecilia Yeung, Andreas Hochhaus
Publikováno v:
Leukemia, 36, 7, pp. 1703-1719
Leukemia
Leukemia, 2022, 36 (7), pp.1703-1719. ⟨10.1038/s41375-022-01613-1⟩
Leukemia, 36, 1703-1719
Khoury, J D, Solary, E, Abla, O, Akkari, Y, Alaggio, R, Apperley, J F, Bejar, R, Berti, E, Busque, L, Chan, J K C, Chen, W, Chen, X, Chng, W-J, Choi, J K, Colmenero, I, Coupland, S E, Cross, N C P, de Jong, D, Elghetany, M T, Takahashi, E, Emile, J-F, Ferry, J, Fogelstrand, L, Fontenay, M, Germing, U, Gujral, S, Haferlach, T, Harrison, C, Hodge, J C, Hu, S, Jansen, J H, Kanagal-Shamanna, R, Kantarjian, H M, Kratz, C P, Li, X-Q, Lim, M S, Loeb, K, Loghavi, S, Marcogliese, A, Meshinchi, S, Michaels, P, Naresh, K N, Natkunam, Y, Nejati, R, Ott, G, Padron, E, Patel, K P, Patkar, N, Picarsic, J, Platzbecker, U, Roberts, I, Schuh, A, Sewell, W, Siebert, R, Tembhare, P, Tyner, J, Verstovsek, S, Wang, W, Wood, B, Xiao, W, Yeung, C & Hochhaus, A 2022, ' The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours : Myeloid and Histiocytic/Dendritic Neoplasms ', Leukemia, vol. 36, no. 7, pp. 1703-1719 . https://doi.org/10.1038/s41375-022-01613-1
Leukemia
Leukemia, 2022, 36 (7), pp.1703-1719. ⟨10.1038/s41375-022-01613-1⟩
Leukemia, 36, 1703-1719
Khoury, J D, Solary, E, Abla, O, Akkari, Y, Alaggio, R, Apperley, J F, Bejar, R, Berti, E, Busque, L, Chan, J K C, Chen, W, Chen, X, Chng, W-J, Choi, J K, Colmenero, I, Coupland, S E, Cross, N C P, de Jong, D, Elghetany, M T, Takahashi, E, Emile, J-F, Ferry, J, Fogelstrand, L, Fontenay, M, Germing, U, Gujral, S, Haferlach, T, Harrison, C, Hodge, J C, Hu, S, Jansen, J H, Kanagal-Shamanna, R, Kantarjian, H M, Kratz, C P, Li, X-Q, Lim, M S, Loeb, K, Loghavi, S, Marcogliese, A, Meshinchi, S, Michaels, P, Naresh, K N, Natkunam, Y, Nejati, R, Ott, G, Padron, E, Patel, K P, Patkar, N, Picarsic, J, Platzbecker, U, Roberts, I, Schuh, A, Sewell, W, Siebert, R, Tembhare, P, Tyner, J, Verstovsek, S, Wang, W, Wood, B, Xiao, W, Yeung, C & Hochhaus, A 2022, ' The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours : Myeloid and Histiocytic/Dendritic Neoplasms ', Leukemia, vol. 36, no. 7, pp. 1703-1719 . https://doi.org/10.1038/s41375-022-01613-1
The upcoming 5th edition of the World Health Organization (WHO) Classification of Haematolymphoid Tumours is part of an effort to hierarchically catalogue human cancers arising in various organ systems within a single relational database. This paper
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e505729c9f9bde8ff82d51d719fed2e
http://hdl.handle.net/10044/1/103319
http://hdl.handle.net/10044/1/103319
Publikováno v:
American Journal of Clinical Pathology. 158:S28-S28
Objective Myeloid neoplasms (MNs) harboring inv(3)(q21q26)/t(3;3)(q21;q26) or MECOM gene rearrangements as identified by fluorescence in situ hybridization (FISH) are known to carry a poor prognosis. The objective of this study is to assess prognosti
Autor:
Daniel Xia, Sagi Abelson, Jose-Mario Capo-Chichi, Robert P. Hasserjian, Rosemarie Tremblay-Le May, Phillip Michaels
Publikováno v:
Journal of Clinical Pathology. 72:453-459
Clonal haematopoiesis (CH) is defined by the presence of acquired mutations and/or cytogenetic abnormalities in haematopoietic cells. By definition, these premalignant clones do not meet criteria for haematopoietic neoplasms listed in the Revised Fou
Autor:
Phillip Michaels
Publikováno v:
American journal of clinical pathology. 157(3)
Publikováno v:
Blood Adv
The classification, risk stratification, and treatment selection of patients with hematologic malignancies are heavily influenced by recurrent molecular alterations determined by next-generation sequencing (NGS).1-5 Peripheral blood (PB) and bone mar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac1cc1340aa53de2ba58a28ff08a7838
https://europepmc.org/articles/PMC7509881/
https://europepmc.org/articles/PMC7509881/
Publikováno v:
Modern Pathology. 34:2084
Autor:
Christopher M. Anderson, Timothy W. Schmidt, Rob Sharp, Phillip Michaels, Lawrence S. Bernstein, H. Van Winckel, Robert J. Glinski, Michael L. Sitko
Publikováno v:
Astrophysics and Space Science. 323:337-344
In this paper we discuss our insights into several key problems in the identification of the Red Rectangle Bands (RRBs). We have combined three independent sets of observations in order to try to define the constraints guiding the bands. We provide a
Autor:
Robin Joyce, Venkata Thodima, Daniel Xia, Phillip Michaels, Sitharthan Kamalakaran, Rajan Dewar, Julia Friedman, Asha Guttapalli, Timothy George Lens, Jane Houldsworth
Publikováno v:
Blood. 126:3910-3910
Introduction: Diffuse Large B-cell Lymphoma (DLBCL), exhibits a wide range of clinical and biological heterogeneity. While initially responsive to rituximab based therapy, more than 70% of patients relapse within 5 years. Two distinct subtypes of DLB